Basket 07 — Women's Health
Women's Health
Gynaecology Basket
Women's health and hormone basket for oral contraceptives, emergency contraception, endometriosis and hormone therapy opportunities.
Portfolio Products — 12 molecules
Gynaecology · Women's Health
Every decade brings a different hormonal question.
Women's health is not a single condition — it is a lifelong hormonal narrative. From the first menstrual cycle to the last, the central characters are oestrogen and progesterone. When they are balanced, life proceeds. When they shift — through contraceptive choice, endometriosis, pregnancy, or menopause — clinical intervention becomes a question of quality of life.
Our gynaecology portfolio spans the full arc of that journey: contraception, disorder management, fertility support, and hormonal restoration.
Phase 1
Reproductive Years
Contraception, cycle regulation & hormonal balance
The first question is always hormonal. Whether managing an irregular cycle, preventing pregnancy, or treating PCOS — oestrogen and progestogen combinations form the pharmacological foundation of women's reproductive health. The science is decades deep; the art is in choosing the right combination for the right patient.
Portfolio Molecules
Ethinylestradiol + Levonorgestrel
Combined OCP
Ethinylestradiol + Cyproterone
OCP / PCOS / anti-androgen
Ethinylestradiol + Dienogest
Combined OCP / endometriosis
Levonorgestrel
Emergency & regular contraception
Phase 2
Endometriosis & Gynaecological Disorders
A condition affecting 1 in 10 women — still widely under-diagnosed
Endometriosis takes an average of 7–10 years to diagnose. By the time a woman has a name for her pain, her quality of life has often been compromised for nearly a decade. Modern progestogen therapy — particularly with high-selectivity molecules — has transformed the management approach.
Portfolio Molecules
Dienogest
High-specificity progestogen for endometriosis
Norethisterone
Endometriosis / menstrual disorders
Medroxyprogesterone
Endometriosis / HRT
Dydrogesterone
Luteal support / recurrent miscarriage
Phase 3
Perimenopause & Beyond
Hormonal transition — managing the continuum
Menopause is not a disease. But the hormonal transition surrounding it — the vasomotor symptoms, the urogenital changes, the mood disruption — deserves the same rigorous clinical attention as any chronic condition. Hormone replacement therapy, when prescribed thoughtfully, is one of the most evidence-backed interventions in medicine.
Portfolio Molecules
Estradiol
HRT — vasomotor & urogenital symptoms
Progesterone
Endometrial protection in HRT
Dydrogesterone
HRT progestogen component
Medroxyprogesterone
Systemic HRT
1 in 10
Women affected by endometriosis globally
₹1,632 Mn
SSPL gynaecology portfolio — MAT Mar 2026
3 phases
Reproductive · Disorders · Perimenopause